About

Clarity Before Complexity

Deb Boucher is a Vice Chair at Cushman & Wakefield. She works exclusively with occupiers of space and advises clients on real estate decisions where timing, capital, and operational priorities must align with precision.

With more than two decades of experience, she works with organizations across life science and advanced tech industries, where real estate decisions are closely tied to business milestones. Her approach is to create clarity and optionality early, before the transaction progresses so far that available choices become constrained.

She brings together detailed analysis and strong commercial judgement to complex decisions, helping clients connect real estate decisions to broader business outcomes. Her focus is on ensuring that operational realities are understood early and revisited, so that real estate continues to support the business effectively.

Where Deb Brings Smart Advice

• Life sciences and advanced manufacturing real estate strategy
• Complex lease negotiations and transaction structuring
• Stakeholder alignment and decision-making processes
• Capital planning, budget validation and timeline management
• Portfolio strategy across growth, contraction and operational change
• Translating business priorities into real estate decisions

How Deb Works

She builds clarity early.
Deb focuses on understanding client dynamics, stakeholder priorities and decision pathways at the outset, creating alignment before complexity emerges. 

She structures complex decisions.
By synthesizing multiple inputs, Deb helps clients prioritize what matters and move forward with clarity and direction.

She brings risk to the surface early. 
Deb helps clients understand risk and make informed decisions that are supported by data and clear next steps.

Awards & Recognition

• Cushman & Wakefield D.R.I.V.E. Award, 2024
• Triangle Commercial Real Estate Women15 Years of Service Award, 2024
• Cushman & Wakefield Americas Transformation Deal Award, 2023
• Triangle Business Journal SPACE Award for Largest Life Science transaction, 2023
• Triangle Commercial Real Estate Women Professional Service Award, 2022
• Cushman & Wakefield Tenant Advisory Group Outstanding Achievement Award, 2022
• GlobeSt’s Women of Influence Top Brokers in Tenant Representation, 2021
• Real Estate Forum’s 50 Under 40, 2019
• Cushman & Wakefield Tenant Advisory Group Excellence in Mentoring Award, 2019
• Triangle Commercial Real Estate Women Rising Leader, 2019
• Cushman & Wakefield Excellence in Mentoring Award, 2019
• Triangle Business Journal SPACE Award for Largest Flex Lease transaction, 2018
• Cushman & Wakefield Americas Standing Ovation Award, 2016
• Triangle Business Journal 40 Under 40 Leadership Award, 2013
• Cassidy Turley Rising Star, Class of 2013

Affiliations

• Cushman & Wakefield Life Sciences Advisory Group, Americas Co-Lead 
• Cushman & Wakefield, Raleigh-Durham Life Science Practice, Lead
• North Carolina Biotechnology Center Life Science Economic Development Advisory Council
• Triangle Commercial Real Estate Women (TCREW) 
• Cushman & Wakefield Tenant Advisory Group, Executive Committee, Mentor
• Cushman & Wakefield Industrial Forum

Clients

• AbbVie
• Adverum
• Affinia Therapeutics
• Astrazeneca
• Aurobindo Pharma
• AveXis, a Novartis Company
• Bayer CropScience
• Bespak
• BioAgilytix Labs
• Biogen
• Braeburn Pharmaceuticals
• Catalent Pharma Solutions
• Coriolis Pharma
• CRISPR Therapeutics
• DuPont & Pioneer Hi-Bred
• G1 Therapeutics
• Impact Pharma Services
• Inceptor Bio
• INTAS / Accord Healthcare
• KBI BioPharma
• Kriya Therapeutics
• Kymanox Corporation
• Lifestar Pharma
• Medicago
• Medline
• NeoGenomics
• Novartis
• Novonesis
• Pfizer
• Precison BioSciences
• Reckitt
• Seqirus
• Targan
• Taysha Gene Therapies
• Tergus Pharma
• Topsoe
• UCB Biosciences
• Velocity Clinical Research
• Zoetis

My Team

Deb Boucher, Kathryn Lawn, Kate Boyle and Callie Hall are the Triangle's premier commercial real estate advisory team focused on the Science and Advanced Technology sectors.